课题基金 / 基金详情

项目摘要

项目成果

Juan Carlos Ramos的其他基金

相似基金

相关文献

中文摘要
翻译
迈阿密大学(UM)-迈阿密是美国最大的大都市区之一,拥有 HIV-1感染发生率。佛罗里达州约有12.5万艾滋病毒携带者(全国3‘*^人), 67%是黑人或西班牙裔(佛罗里达州卫生部,艾滋病毒/艾滋病情况说明书,2008年)。迈阿密戴德县 占该州艾滋病毒感染者的20%。艾滋病毒/艾滋病是#年的头号死因。 非洲裔美国人的年龄在25-44岁之间。在迈阿密-戴德县,艾滋病毒感染患者主要在我们的 附属杰克逊纪念医院(JMH),这是一家拥有1500张床位的三级医院,为市中心、贫困和 在玛格丽特·菲斯基博士指导下的密歇根大学艾滋病临床研究中心(ACRU)。更多 最近,UM扩大了其临床和教学业务,收购了邻近我们的560个床位的设施 位于迈阿密市中心的癌症中心。UM/JMH的艾滋病毒方案自20世纪80年代初以来一直存在,S说, 对艾滋病的临床护理和研究做出了重大贡献。成人艾滋病毒门诊计划如下 大约2600名感染艾滋病毒的成年人,每年有超过8000人次的门诊就诊。约30% 是女性,45%是非洲裔美国人,15%是海菲亚裔美国人,30%是西班牙裔美国人,其余是欧洲人- 美国人。
英文摘要
University Miami (UM) - Miami is one ofthe largest metropolitan areas in the United States with the highest incidence of HIV-1 infecfion. Approximately 125,000 people are living with HIV in Florida (3'*^ in the nation) and 67% are black or Hispanic (Florida Department of Health, HIV/AIDS Fact Sheet, 2008). Miami Dade County accounts for 20% of those with HIV infection in the state. HIV/AIDS is the number one cause of death in African Americans ages 25-44. In Miami-Dade County, HIV-infected patients are primarily followed at our affiliated Jackson Memorial Hospital (JMH), a 1500-bed tertiary facility that serves an inner-city, indigent, and minority population and at UM's AIDS Clinical Research Unit (ACRU) directed by Dr. Margaret FischI. More recently, UM has expanded its clinical and teaching operations acquiring a 560-bed facility adjacent to our cancer center in the heart of Miami. The HIV program at UM/JMH has existed since the eariy 1980's and has contributed significanfiy to HIV dinical care and research. The adult HIV outpatient program follows approximately 2,600 HIV-infected adult individuals with over 8,000 outpatient visits a year. Approximately 30% are female, 45% African-American, 15% Haifian-American, 30% Hispanic-American, and the remainder Euro- American.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma
University of Miami Core Site
Targeting of EBV Latency in Burkitt's Lymphoma
海外基金